Golden Minerals Company (NYSE:AUMN) tinted gains of +3.68% (+0.01 points) to US$0.38. The volume of 0.14 Million shares climbed down over an trading activity of 112.6 Million shares. EPS ratio determined by looking at last 12 month figures is -0.04. Over the same time span, the stock marked US$0.68 as its best level and the lowest price reached was US$0.36. The corporation has a market cap of US$36.73 Million.
Golden Minerals Company (NYSE:AUMN)’s earnings per share has been growing at a 55.5 percent rate over the past 5 year when average revenue increase was noted as -23.8 percent. The return on equity ratio or ROE stands at 0 percent while most common profitability ratio return on investment (ROI) was -47.9 percent. The company’s institutional ownership is monitored at 49.1 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 67.8 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 0 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 0 think it is Hold. Recently, analysts have updated the overall rating to 2. 1 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.
Vital Therapies, Inc. (NASDAQ:VTL) is worth US$256.17 Million and has recently risen 3.67% to US$5.65. The latest exchange of 0.23 Million shares is below its average trading activity of 236.54 Million shares. The day began at US$5.4 but the price moved to US$5.4 at one point during the trading and finally capitulating to a session high of US$5.7. The stock tapped a 52-week high of US$7.3 while the mean 12-month price target for the shares is US$9.
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 6.42, and a price to sales ratio of 0. For the past 5 years, the company’s revenue has grown 0%, while the company’s earnings per share has grown -29.3%. With an institutional ownership near 27.7%, it carries an earnings per share ratio of -1.27.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 2 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.67.